Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARTIVION, INC.AORT · Entity 4767 | President & CEO | August 19, 2026 | August 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARTIVION, INC.
Report date August 19, 2026 · Filed August 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 877,275 |
Reported balance
After 2026-08-19 transaction · row 1
1 source rowRow 1 · 2026-08-19 · Sale · Disposed 70,000 · Balance 877,275 F1: Reflects weighted average price. Range of prices were between $28.89 to $29.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects weighted average price. Range of prices were between $28.89 to $29.15. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Wright Medical Group N.V.
Report date November 11, 2020 · Filed November 13, 2020
Section 16 reporting ended · disclosed 2020-11-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value EUR 0.03 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 1
1 source rowRow 1 · 2020-11-11 · Other · Disposed 11,720 · Balance 0 F1: On November 4, 2019, Wright Medical Group N.V. (the Issuer) entered into a purchase agreement (the Purchase Agreement) with Stryker Corporation and its subsidiary, Stryker B.V. (the Purchaser). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (Shares), of the Issuer (the Offer), and on November 11, 2020 (the Acceptance Time), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer, including 11,720 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the Offer Consideration), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement) |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $27.84 · Expires 2029-07-26 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-11-11 · Disposition to issuer · Disposed 11,691 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $24.49 · Expires 2028-07-24 | Direct | 0 |
Reported balance
After 2020-11-11 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-11-11 · Disposition to issuer · Disposed 9,907 · Balance 0 F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 4, 2019, Wright Medical Group N.V. (the Issuer) entered into a purchase agreement (the Purchase Agreement) with Stryker Corporation and its subsidiary, Stryker B.V. (the Purchaser). Pursuant to the terms of the Purchase Agreement, the Purchaser commenced a tender offer for all the outstanding ordinary shares, par value EUR 0.03 per share (Shares), of the Issuer (the Offer), and on November 11, 2020 (the Acceptance Time), the Purchaser accepted all of the Shares that were validly tendered and not properly withdrawn pursuant to the Offer, including 11,720 Shares tendered by the reporting person, in exchange for a cash payment equal to $30.75 per Share, without interest and less applicable withholding taxes (the Offer Consideration), which Offer Consideration will be paid as promptly as practicable following the Closing (as defined in the Purchase Agreement)
F2: Pursuant to the Purchase Agreement, each outstanding option to purchase Shares (a Wright Stock Option) that was outstanding immediately prior to the Acceptance Time was automatically canceled at the Acceptance Time and, at the Closing, exchanged for a cash payment equal to the product of (a) the number of Shares subject to the unexercised portion of such Wright Stock Option immediately prior to the Acceptance Time multiplied by (b) the excess, if any, of $30.75 over the applicable per Share exercise price of such Wright Stock Option, without interest and less applicable withholding taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2020 Filed Mar 16, 2020 11:52 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 2,674 | $20.24 | $54,121.76 |
DisclosureSEC source: 0000784199-20-000085 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,774 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:52 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000085 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,448 F1 · balance_after: Balance reflects a share correction that was duplicated on 02.21.2020. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:14 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 4,455 | $24.93 | $111,063.15 |
DisclosureSEC source: 0000784199-20-000065 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,448 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:14 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 19,756 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000065 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,903 F1 · shares: Represents performance stock units granted on March 5, 2019 and earned at approximately 82.5% of target based on 2019 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2020. The remaining shares earned in connection with the March 2019 grant will vest and be issued as follows: 25% on 03/05/2021, and 25% on 03/5/2022, assuming continued employment on the relevant vesting date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:37 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 3,157 | $26.20 | $82,713.40 |
DisclosureSEC source: 0000784199-20-000049 · certent-form4.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,147 F3 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:37 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000049 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,304 F2 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:37 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 6,842 | $26.20 | $179,260.40 |
DisclosureSEC source: 0000784199-20-000049 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,304 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:10 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantStock Option(Right to Buy) · Derivative | 86,296 | $0.00 Strike: $26.24 | $0.00 |
DisclosureSEC source: 0000784199-20-000033 · certent-form4.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,296 Underlying: Common Stock · 86,296 shares Expires 2027-02-19 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:10 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 28,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-20-000033 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,146 F1 · shares: Represents shares of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| November 13, 2019 Filed Nov 13, 2019 21:14 UTC | ARTIVION, INC. CRY · Entity 4767 | PurchaseCommon Stock | 5,000 | $23.47 | $117,355.00 |
DisclosureSEC source: 0000784199-19-000162 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,731 F1 · price: Reflects open market purchase by reporting person. Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 16:32 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantStock Option (right to buy) · Derivative | 11,691 | $0.00 Strike: $27.84 | $0.00 |
DisclosureSEC source: 0001235802-19-000079 · primary_doc.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,691 Underlying: Ordinary Shares · 11,691 shares Expires 2029-07-26 Read SEC document |
| July 26, 2019 Filed Jul 30, 2019 16:32 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantOrdinary Shares, par value EUR 0.03 per share | 3,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-19-000079 · primary_doc.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,720 F1 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. F2 · balance_after: Includes 3,916 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan. Read SEC document |
| May 03, 2019 Filed May 7, 2019 20:53 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 50,000 | $31.31 | $1,565,690.00 |
DisclosureSEC source: 0000784199-19-000100 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,731 F1 · price: Reflects weighted average price. Range of prices were between $31.05 to $31.64. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:58 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 5,218 | $29.82 | $155,600.76 |
DisclosureSEC source: 0000784199-19-000086 · certent-form4.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,731 F3 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:58 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 23,427 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000086 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,949 F2 · shares: Represents performance stock units granted on March 12, 2018 and earned at approximately 80% of target based on 2018 adjusted EBITDA. Fifty percent (50%) were issued on March 14, 2018. The remaining shares earned in connection with the March 2018 grant will vest and be issued as follows: 50% on 03/12/2020, and 50% on 03/12/2021, assuming continued employment on the relevant vesting date. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:58 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 19 | $29.70 | $564.30 |
DisclosureSEC source: 0000784199-19-000086 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,522 F1 · shares: This is an adjustment to the shares withheld for taxes for the 3/1/2019 PSU Vesting. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:49 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantStock Option (Right to Buy) · Derivative | 61,842 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0000784199-19-000056 · certent-form4.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,842 Underlying: Common Stock · 61,842 shares Expires 2026-03-05 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:49 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 23,948 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000056 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,541 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 13:19 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 8,103 | $29.70 | $240,659.10 |
DisclosureSEC source: 0000784199-19-000041 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,593 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:24 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 6,602 | $28.84 | $190,401.68 |
DisclosureSEC source: 0000784199-19-000010 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,696 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| August 28, 2018 Filed Aug 29, 2018 20:54 UTC | ARTIVION, INC. CRY · Entity 4767 | OtherCommon Stock | 34,600 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000181 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,298 F1 · shares: Shares were transferred to ex-wife pursuant to divorce decree. Read SEC document |
| August 15, 2018 Filed Aug 15, 2018 21:48 UTC | ARTIVION, INC. CRY · Entity 4767 | Exercise / conversionStock Options (Right to Buy) · Derivative | 9,851 | $10.24 Strike: $10.24 | $100,874.24 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · derivative · entry 9 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,265 Underlying: Common Stock · 9,851 shares Expires 2021-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 9/2/2015 Read SEC document |
| August 15, 2018 Filed Aug 15, 2018 21:48 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 9,851 | $31.79 | $313,208.60 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · nonDerivative · entry 6 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,898 F3 · price: Reflects weighted average price. Range of prices were between $31.75 to $31.90. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 15, 2018 Filed Aug 15, 2018 21:48 UTC | ARTIVION, INC. CRY · Entity 4767 | Exercise / conversionCommon Stock | 9,851 | $10.24 | $100,874.24 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · nonDerivative · entry 5 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 21:48 UTC | ARTIVION, INC. CRY · Entity 4767 | Exercise / conversionStock Options (Right to Buy) · Derivative | 37,077 | $10.24 Strike: $10.24 | $379,668.48 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · derivative · entry 8 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,116 Underlying: Common Stock · 37,077 shares Expires 2021-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 9/2/2015 Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 21:48 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 37,077 | $32.22 | $1,194,472.63 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · nonDerivative · entry 4 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,898 F2 · price: Reflects weighted average price. Range of prices were between $32.00 to $32.95. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 21:48 UTC | ARTIVION, INC. CRY · Entity 4767 | Exercise / conversionCommon Stock | 37,077 | $10.24 | $379,668.48 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · nonDerivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 21:48 UTC | ARTIVION, INC. CRY · Entity 4767 | Exercise / conversionStock Options (Right to Buy) · Derivative | 103,072 | $10.24 Strike: $10.24 | $1,055,457.28 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · derivative · entry 7 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,193 Underlying: Common Stock · 103,072 shares Expires 2021-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 9/2/2015 Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 21:48 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 103,072 | $32.17 | $3,315,949.93 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,898 F1 · price: Reflects weighted average price. Range of prices were between $32.00 to $32.625. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 21:48 UTC | ARTIVION, INC. CRY · Entity 4767 | Exercise / conversionCommon Stock | 103,072 | $10.24 | $1,055,457.28 |
DisclosureSEC source: 0000784199-18-000173 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 20:43 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 19,152 | $33.67 | $644,916.79 |
DisclosureSEC source: 0000784199-18-000169 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,898 F2 · price: Reflects weighted average price. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 10, 2018 Filed Aug 13, 2018 20:43 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 23,523 | $33.03 | $777,051.73 |
DisclosureSEC source: 0000784199-18-000169 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,050 F1 · price: Reflects weighted average price. Range of prices were between $32.80 to $33.60. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:26 UTC | ARTIVION, INC. CRY · Entity 4767 | OtherStock Option (Right to Buy) · Derivative | 28,412 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000155 · certent-form4.xml · derivative · entry 5 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,225 Underlying: Common Stock · 28,412 shares Expires 2024-02-21 F1 · shares: Shares were transferred to ex-wife pursuant to divorce decree. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:26 UTC | ARTIVION, INC. CRY · Entity 4767 | OtherStock Option (Right to Buy) · Derivative | 54,123 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000155 · certent-form4.xml · derivative · entry 4 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,549 Underlying: Common Stock · 54,123 shares Expires 2023-02-19 F1 · shares: Shares were transferred to ex-wife pursuant to divorce decree. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:26 UTC | ARTIVION, INC. CRY · Entity 4767 | OtherStock Option (Right to Buy) · Derivative | 42,552 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000155 · certent-form4.xml · derivative · entry 3 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,553 Underlying: Common Stock · 42,552 shares Expires 2022-02-19 F1 · shares: Shares were transferred to ex-wife pursuant to divorce decree. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:26 UTC | ARTIVION, INC. CRY · Entity 4767 | OtherStock Option (Right to Buy) · Derivative | 204,266 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000155 · certent-form4.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,265 Underlying: Common Stock · 204,266 shares Expires 2021-09-02 F1 · shares: Shares were transferred to ex-wife pursuant to divorce decree. Read SEC document |
| August 09, 2018 Filed Aug 9, 2018 21:26 UTC | ARTIVION, INC. CRY · Entity 4767 | OtherCommon Stock | 30,522 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000155 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,573 F1 · shares: Shares were transferred to ex-wife pursuant to divorce decree. Read SEC document |
| August 07, 2018 Filed Aug 9, 2018 21:26 UTC | ARTIVION, INC. CRY · Entity 4767 | OtherStock Option (Right to Buy) · Derivative | 1,947 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000155 · certent-form4.xml · derivative · entry 6 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,615 Underlying: Common Stock · 1,947 shares Expires 2025-03-12 F1 · shares: Shares were transferred to ex-wife pursuant to divorce decree. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 21:05 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantStock Option (right to buy) · Derivative | 9,907 | $0.00 Strike: $24.49 | $0.00 |
DisclosureSEC source: 0001235802-18-000115 · primary_doc.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,907 Underlying: Ordinary Shares · 9,907 shares Expires 2028-07-24 F3 · derivative.exercise_date: This option vests in two annual installments, on the one-year and two-year anniversaries of July 24, 2018. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 21:05 UTC | Wright Medical Group N.V. WMGI · Entity 145358 | GrantOrdinary Shares, par value EUR 0.03 per share | 3,804 | $0.00 | $0.00 |
DisclosureSEC source: 0001235802-18-000115 · primary_doc.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,804 F1 · shares: These ordinary shares will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. F2 · balance_after: Includes 3,804 ordinary shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:51 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantStock Option (Right to Buy) · Derivative | 77,562 | $0.00 Strike: $21.55 | $0.00 |
DisclosureSEC source: 0000784199-18-000073 · certent-form4.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,562 Underlying: Common Stock · 77,562 shares Expires 2025-03-12 Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 23:51 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 30,162 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000073 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,095 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:26 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 6,349 | $19.15 | $121,583.35 |
DisclosureSEC source: 0000784199-18-000050 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,933 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 22:26 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-18-000050 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,282 F1 · shares: Represents performance stock units granted on February 21, 2017 and earned at approximately 90% of target based on 2017 adjusted EBITDA. Fifty percent (50%) were issued on March 5, 2018. The remaining shares earned in connection with the February 2017 grant will vest and be issued as follows: 50% on 02/21/2019, and 50% on 02/21/2020, assuming continued employment on the relevant vesting date. Read SEC document |
| February 19, 2018 Filed Feb 22, 2018 00:44 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 9,527 | $18.25 | $173,867.75 |
DisclosureSEC source: 0000784199-18-000028 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,282 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:23 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 4,591 | $18.25 | $83,785.75 |
DisclosureSEC source: 0000784199-18-000024 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,809 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 19, 2018 Filed Feb 21, 2018 22:23 UTC | ARTIVION, INC. CRY · Entity 4767 | Tax withholdingCommon Stock | 3,049 | $18.25 | $55,644.25 |
DisclosureSEC source: 0000784199-18-000024 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,400 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| September 06, 2017 Filed Sep 6, 2017 21:43 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 81,950 | $21.97 | $1,800,679.16 |
DisclosureSEC source: 0000784199-17-000084 · certent-form4.xml · nonDerivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,449 F1 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. F2 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 27, 2017. F4 · price: Reflects weighted average price. Range of prices were between $21.90 to $22.10. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 05, 2017 Filed Sep 6, 2017 21:43 UTC | ARTIVION, INC. CRY · Entity 4767 | SaleCommon Stock | 43,050 | $22.09 | $951,060.60 |
DisclosureSEC source: 0000784199-17-000084 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,399 F1 · shares: These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. F2 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on February 27, 2017. F3 · price: Reflects weighted average price. Range of prices were between $21.85 to $22.45. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 23:58 UTC | ARTIVION, INC. CRY · Entity 4767 | GrantCommon Stock | 31,111 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000021 · certent-form4.xml · nonDerivative · entry 4 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,449 F3 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.